Economics of prostate cancer screening: Racial implications

Endocrine-Related Cancer

Volumn 3, Issue 3, 1996, Pages 199-203

  Littrup, P J ^a  

^a WAYNE STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER SCREENING; COST EFFECTIVENESS ANALYSIS; EARLY DIAGNOSIS; ETHNIC GROUP; HEALTH ECONOMICS; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; NEGRO; PROSTATE BIOPSY; PROSTATE CANCER; RACE DIFFERENCE; TRANSRECTAL ULTRASONOGRAPHY;

EID: 0029910873     PISSN: 13510088     EISSN: None     Source Type: Journal    
DOI: 10.1677/erc.0.0030199     Document Type: Article

References (13)

1. Babaian RJ, Mettlin C, Kane R, Murphy GP & the Investigators of the ACS-NPCDP 1992 The relationship of prostate specific antigen to digital rectal examination and transrectal ultrasonography. Cancer 69 1195-1200.
2. Catalona WJ, Smith DS, Ratliff TL et al. 1991 Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. New England Journal of Medicine 324 1156-1161.
3. Catalona WJ, Smith DS, Ratliff TL & Basler JW 1993 Detection of organ-confined prostate cancer is increased through prostate-specific antigen-based screening. Journal of the American Medical Association 270 948-954.
4. Cooner WH, Mosley BR, Rutherford CL et al. 1990 Prostate cancer detection in a clinical urological practice by ultrasonography, digital rectal examination and prostate specific antigen. Journal of Urology 143 1146-1152.
5. Demers RY, Swanson GM, Weiss LK & Kau-Tsing-Ying 1994 Increasing incidence of cancer of the prostate: The experience of black and white men in the Detroit Metropolitan Area. Archives of Internal Medicine 154 1211-1216.
6. Kane RA, Littrup PJ, Babaian R, Murphy GP & the Investigators of the ACS-NPCDP 1992 PSA levels in 1695 men without evidence of prostate cancer: findings of the American Cancer Society National Prostate Cancer Detection Project. Cancer 69 1201-1207.
7. Littrup PJ & Goodman A for the Investigators of the ACS-NPCDP 1995 Economic considerations of prostate cancer the role of detection specificity for biopsy reduction. Cancer 75 (7) (Suppl) 1988-1993.
8. Littrup PJ, Goodman A & Mettlin C for the Investigators of the ACS-NPCDP 1993 The benefit and cost of prostate cancer early detection. Cancer 43 134-149.
9. Littrup PJ, Kane RA, Mettlin CJ, Murphy GP, Lee F, Toi A & the Investigators of the ACS-NPCDP 1994a Cost- effective prostate cancer detection: reduction of low-yield biopsies. Cancer 74 3146-3158.
10. Littrup PJ, Goodman A, Mettlin C, Murphy G & the Investigators of the ACS-NPCDP 1994b Cost analyses of prostate cancer screening: frameworks for discussion. Journal of Urology 152 1873-1877.
11. Mettlin CJ, Lee F, Drago J, Murphy GP & the Investigators of the ACS-NPCDP 1991 The American Cancer Society National Prostate Cancer Detection Project - Findings on the detection of early prostate cancer in 2425 men. Cancer 67 2949-2958.
12. Mettlin C, Jones G, Averette H, Gusberg SB & Murphy G 1993a Defining and updating the American Cancer Society guidelines for the cancer-related checkup: prostate and endometrial cancers. CA Cancer Journal for Clinicians 43 42-46.
13. Mettlin C, Murphy GP, Lee F, Littrup PJ & the Investigators of the ACS-NPCDP 1993b Characteristics of prostate cancers detected in a multimodality early detection program. Cancer 72 1701-1708.